• Docosahexaenoic Acid Enhances Oxaliplatin-Induced Autophagic Cell Death via the ER Stress/Sesn2 Pathway in Colorectal Cancer Jeong S, Kim DY, Kang SH, et al. Docosahexaenoic Acid Enhances Oxaliplatin-Induced Autophagic Cell Death via the ER Stress/Sesn2 Pathway in Colorectal Cancer. Cancers (Basel). 2019;11(7):982. Published 2019 Jul 14. doi:10.3390/cancers11070982 More View

• Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5 Lee YS, Lee DH, Jeong SY, et al. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5. J Cell Biochem. 2019;120(1):928-939. doi:10.1002/jcb.27456 More View

• Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer Jo MJ, Jeong S, Yun HK, et al. Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer. BMC Cancer. 2019;19(1):739. Published 2019 Jul 27. doi:10.1186/s12885-019-5957-x More View

• Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells Jeong S, Yun HK, Jeong YA, et al. Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells. Cancer Lett. 2019;447:12-23. doi:10.1016/j.canlet.2019.01.011 More View

• Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer Kim JL, Kim BR, Kim DY, et al. Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer. Cancers (Basel). 2019;11(5):642. Published 2019 May 9. doi:10.3390/cancers11050642 More View

• Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer Shitara K, Bang YJ, Iwasa S, et al. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer. N Engl J Med. 2020;382(25):2419-2430. doi:10.1056/NEJMoa2004413 More View

• Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously … Al-Batran SE, Van Cutsem E, Oh SC, et al. Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma. Ann Oncol. 2016;27(4):673-679. doi:10.1093/annonc/mdv625 More View

• Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells Jeong S, Kim BG, Kim DY, et al. Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells. Cancers (Basel). 2019;11(6):781. Published 2019 Jun 5. doi:10.3390/cancers11060781 More View

• Hematogenous metastasis of ovarian cancer: rethinking mode of spread Pradeep S, Kim SW, Wu SY, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26(1):77-91. doi:10.1016/j.ccr.2014.05.002 More View

• Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer Jeong S, Jo MJ, Yun HK, et al. Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 2019;10(11):846. Published 2019 Nov 7. doi:10.1038/s41419-019-2001-7 More View